Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HOME DEPOT, INC.HD · Entity 2816 | Director | May 21, 2026 | May 26, 2026 |
| Pediatrix Medical Group, Inc.MD · Entity 4451 | Director | May 12, 2021 | May 14, 2021 |
| REPUBLIC SERVICES, INC.RSG · Entity 1686 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HOME DEPOT, INC.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred SharesSEC Table II · derivative / convertible security | Direct | 8,769.8331 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 796 · Balance 8,769.8331 F1: The Deferred Shares were granted under The Home Depot, Inc. Omnibus Stock Incentive Plan, as amended and restated May 19, 2022, and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. Vesting of shares occurs on the date of the next annual shareholders meeting. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,941.5427 |
Reported balance
After 2026-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-21 · Grant · Acquired 191.2168 · Balance 1,941.5427 F2: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The Deferred Shares were granted under The Home Depot, Inc. Omnibus Stock Incentive Plan, as amended and restated May 19, 2022, and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. Vesting of shares occurs on the date of the next annual shareholders meeting.
F2: The Deferred Stock Units convert to shares of Common Stock on a one-for-one basis following a termination of service as described in The Home Depot, Inc. NonEmployee Directors' Deferred Stock Compensation Plan.
Pediatrix Medical Group, Inc.
Report date May 12, 2021 · Filed May 14, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 129,198 |
Reported balance
After 2021-05-12 transaction · row 1
1 source rowRow 1 · 2021-05-12 · Grant · Acquired 4,885 · Balance 129,198 F1: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 12, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 12, 2022.
REPUBLIC SERVICES, INC.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 40,264.56 |
Reported balance
After 2026-07-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 115.46 · Balance 40,264.56 F1: Based on 1 on 1 conversion. F2: Represents additional Restricted Stock Units (RSUs) accrued as dividends on outstanding RSU awards that will vest and be settled to the extent the RSU is vested and settles. F3: A portion of the Restricted Stock Units are held under the Company's Deferred Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Based on 1 on 1 conversion.
F2: Represents additional Restricted Stock Units (RSUs) accrued as dividends on outstanding RSU awards that will vest and be settled to the extent the RSU is vested and settles.
F3: A portion of the Restricted Stock Units are held under the Company's Deferred Compensation Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NeueHealth, Inc.
Report date October 02, 2025 · Filed October 06, 2025
Section 16 reporting ended · disclosed 2025-10-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-10-02 transaction · row 1
1 source rowRow 1 · 2025-10-02 · Disposition to issuer · Disposed 29,755 · Balance 0 F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F2: Pursuant to the Rollover Agreement, dated as of September 9, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time"). |
| Common StockSEC Table I · non-derivative | IndirectKadre Family Partnership, L.P. | 0 |
Reported balance
After 2025-10-02 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-10-02 · Disposition to issuer · Disposed 3,750 · Balance 0 F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc. F2: Pursuant to the Rollover Agreement, dated as of September 9, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time"). F3: Reflects securities held by the Kadre Family Partnership, L.P. a family limited partnership, of which the Reporting Person is the general partner. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc.
F2: Pursuant to the Rollover Agreement, dated as of September 9, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time").
F3: Reflects securities held by the Kadre Family Partnership, L.P. a family limited partnership, of which the Reporting Person is the general partner.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 17, 2017 Filed Apr 19, 2017 23:11 UTC | REPUBLIC SERVICES, INC. RSG · Entity 1686 | GrantRestricted Stock Units · Derivative | 110 | $62.77 | $6,904.70 |
DisclosureSEC source: 0001209191-17-027562 · doc4.xml · derivative · entry 1 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,436 Underlying: Common Stock · 110 shares Expires not disclosed F1 · derivative.exercise_price: Based on 1 on 1 conversion. F2 · derivative.exercise_date: Dividends paid on the Restricted Stock Units awarded per the Republic Services, Inc. Amended and Restated 2007 Stock Incentive Plan. F2 · derivative.expiration_date: Dividends paid on the Restricted Stock Units awarded per the Republic Services, Inc. Amended and Restated 2007 Stock Incentive Plan. F3 · balance_after: A portion of the Restricted Stock Units are held under the Company's Deferred Compensation Plan. Read SEC document |
| January 16, 2017 Filed Jan 18, 2017 23:56 UTC | REPUBLIC SERVICES, INC. RSG · Entity 1686 | GrantRestricted Stock Units · Derivative | 118 | $57.24 | $6,754.32 |
DisclosureSEC source: 0001209191-17-004312 · doc4.xml · derivative · entry 1 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,326 Underlying: Common Stock · 118 shares Expires not disclosed F1 · derivative.exercise_price: Based on 1 on 1 conversion. F2 · derivative.exercise_date: Dividends paid on the Restricted Stock Units awarded per the Republic Services, Inc. Amended and Restated 2007 Stock Incentive Plan. F2 · derivative.expiration_date: Dividends paid on the Restricted Stock Units awarded per the Republic Services, Inc. Amended and Restated 2007 Stock Incentive Plan. F3 · balance_after: A portion of the Restricted Stock Units are held under the Company's Deferred Compensation Plan. Read SEC document |
| January 03, 2017 Filed Jan 6, 2017 00:36 UTC | REPUBLIC SERVICES, INC. RSG · Entity 1686 | GrantRestricted Stock Units · Derivative | 3,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002401 · doc4.xml · derivative · entry 1 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,869 Underlying: Common Stock · 3,869 shares Expires not disclosed F1 · derivative.exercise_price: Based on a 1 on 1 conversion. F2 · derivative.exercise_date: On 01/03/2017 ("Date of Grant"), each non-Management Director received an annual award of 3,869 Restricted Stock Units ("RSUs") pursuant to the Republic Services, Inc.'s ("Company") 2007 Stock Incentive Plan, as amended. The grant was based on a value on the Date of Grant of $220,000, with the number of RSUs calculated based on the closing stock price of the Company's common stock on the Date of Grant ($56.87). The RSUs under this 01/03/2017 grant immediately vest; however, the Director cannot convert any of the RSUs to Company common stock (based on 1 on 1 conversion) until the earlier of the last day of the month in which the three year anniversary of the date of the award occurs (for this grant being 01/31/2020), unless deferred by the Director or the date on which the Director incurs a separation from service within the meaning of Section 409A of the Internal Revenue Code. The Director elected to defer this grant pursuant to the Company's Deferred Compensation Plan. F2 · derivative.expiration_date: On 01/03/2017 ("Date of Grant"), each non-Management Director received an annual award of 3,869 Restricted Stock Units ("RSUs") pursuant to the Republic Services, Inc.'s ("Company") 2007 Stock Incentive Plan, as amended. The grant was based on a value on the Date of Grant of $220,000, with the number of RSUs calculated based on the closing stock price of the Company's common stock on the Date of Grant ($56.87). The RSUs under this 01/03/2017 grant immediately vest; however, the Director cannot convert any of the RSUs to Company common stock (based on 1 on 1 conversion) until the earlier of the last day of the month in which the three year anniversary of the date of the award occurs (for this grant being 01/31/2020), unless deferred by the Director or the date on which the Director incurs a separation from service within the meaning of Section 409A of the Internal Revenue Code. The Director elected to defer this grant pursuant to the Company's Deferred Compensation Plan. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 8,280 | $36.25 Strike: $36.25 | $300,150.00 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 12 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,280 shares Expires 2021-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 9,922 | $29.36 Strike: $29.36 | $291,260.31 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 11 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,922 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 17,584 | $18.91 Strike: $18.91 | $332,513.44 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 10 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,584 shares Expires 2019-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 10,668 | $27.72 Strike: $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 9 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,668 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 5,174 | $32.33 Strike: $32.33 | $167,249.55 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 8 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,174 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 26,668 | $29.40 Strike: $29.40 | $784,039.20 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 7 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,668 shares Expires 2017-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 8,280 | $36.25 | $300,150.00 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · nonDerivative · entry 6 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 9,922 | $29.36 | $291,260.31 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · nonDerivative · entry 5 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 17,584 | $18.91 | $332,513.44 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · nonDerivative · entry 4 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 10,668 | $27.72 | $295,663.62 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · nonDerivative · entry 3 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 5,174 | $32.33 | $167,249.55 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · nonDerivative · entry 2 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2016 Filed Nov 10, 2016 21:39 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 26,668 | $29.40 | $784,039.20 |
DisclosureSEC source: 0001209191-16-149372 · doc4.xml · nonDerivative · entry 1 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2016 Filed Oct 17, 2016 22:50 UTC | REPUBLIC SERVICES, INC. RSG · Entity 1686 | GrantRestricted Stock Units · Derivative | 110 | $49.82 | $5,480.20 |
DisclosureSEC source: 0001209191-16-146092 · doc4.xml · derivative · entry 1 Kadre Manuel · CIK 0001396538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,339 Underlying: Common Stock · 110 shares Expires not disclosed F1 · derivative.exercise_price: Based on 1 on 1 conversion. F2 · derivative.exercise_date: Dividends paid on the Restricted Stock Units awarded per the Republic Services, Inc. Amended and Restated 2007 Stock Incentive Plan. F2 · derivative.expiration_date: Dividends paid on the Restricted Stock Units awarded per the Republic Services, Inc. Amended and Restated 2007 Stock Incentive Plan. F3 · balance_after: A portion of the Restricted Stock Units are held under the Company's Deferred Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.